These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10516936)

  • 1. The pharmacokinetics of extended-release formulations of calcium antagonists and of amlodipine in subjects with different gastrointestinal transit times.
    Zimmermann T; Laufen H; Yeates R; Scharpf F; Riedel KD; Schumacher T
    J Clin Pharmacol; 1999 Oct; 39(10):1021-31. PubMed ID: 10516936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crossover comparison of the pharmacokinetics of amlodipine and felodipine ER in hypertensive patients.
    Videbaek LM; Jacobsen IA
    Int J Clin Pharmacol Ther; 1997 Nov; 35(11):514-8. PubMed ID: 9401833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinetic profiles of amlodipine and of a sustained release form of diltiazem.
    Fourtillan JB; Ingrand I; Decourt JP; Istin B; Girault J
    Therapie; 1998; 53(2):121-6. PubMed ID: 9773111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and bioequivalence study of a generic amlodipine tablet formulation in healthy male volunteers.
    Sailer R; Arnold P; Erenmemişoğlu A; Martin W; Tamur U; Kanzik I; Hincal AA
    Arzneimittelforschung; 2007; 57(7):462-6. PubMed ID: 17803059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of amlodipine versus felodipine extended release on 24-hour ambulatory blood pressure in hypertension.
    Ostergren J; Isaksson H; Brodin U; Schwan A; Ohman KP
    Am J Hypertens; 1998 Jun; 11(6 Pt 1):690-6. PubMed ID: 9657628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects.
    Kirigaya Y; Shiramoto M; Ishizuka T; Uchimaru H; Irie S; Kato M; Shimizu T; Nakatsu T; Nishikawa Y; Ishizuka H
    BMC Pharmacol Toxicol; 2020 Jul; 21(1):55. PubMed ID: 32727577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence, pharmacokinetic and pharmacodynamic response to combined extended release formulations of felodipine and metoprolol in healthy volunteers.
    Aberg J; Abrahamsson B; Grind M; Nyberg G; Olofsson B
    Eur J Clin Pharmacol; 1997; 52(6):471-7. PubMed ID: 9342583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of repeated oral doses of amlodipine and amlodipine plus telmisartan in healthy volunteers.
    Stangier J; Su CA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1347-54. PubMed ID: 11185633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetic and pharmacodynamic characteristics of amlodipine besylate and amlodipine nicotinate in healthy subjects.
    Park JY; Kim KA; Park PW; Lee OJ; Kim JS; Lee GH; Ha MC; Park JH; O MJ; Ryu JH
    Int J Clin Pharmacol Ther; 2006 Dec; 44(12):641-7. PubMed ID: 17190374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence and relative bioavailability of a new diltiazem sustained release formulation.
    Scheiwe MW; Lankhaar G; Kleinbloesem CH
    Arzneimittelforschung; 1996 Oct; 46(10):960-3. PubMed ID: 8931888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interaction of telmisartan with s-amlodipine: an open-label, two-period crossover study in healthy Korean male volunteers.
    Noh YH; Lim HS; Kim MJ; Kim YH; Choi HY; Sung HR; Jin SJ; Lim J; Bae KS
    Clin Ther; 2012 Jul; 34(7):1625-35. PubMed ID: 22721873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter studies on the pharmacokinetic profile of sustained-release oral diltiazem (300 mg) after once a day repeated administration: influence of age.
    Bianchetti G; Billy S; Ascalone V; Saivin S; Houin G; Rosenzweig P
    Int J Clin Pharmacol Ther; 1996 May; 34(5):195-201. PubMed ID: 8738855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD.
    Sajkov D; Wang T; Frith PA; Bune AJ; Alpers JA; McEvoy RD
    Chest; 1997 Jun; 111(6):1622-30. PubMed ID: 9187185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study comparing biopharmaceutic characteristics of four once daily controlled release diltiazem preparations.
    Hendriks MG; Dogterom P; Ebels JT; Oosterhuis B; Geertsema LR; Hulot T; Bianchetti G; Jonkman JH
    Fundam Clin Pharmacol; 1998; 12(5):559-65. PubMed ID: 9794155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetics of a single oral dose of two formulations of amlodipine. A randomized, single-blind, two-period, two-sequence, crossover study.
    Pico JC; Domínguez G; Negri AL; Caubet JC; Terragno NA
    Arzneimittelforschung; 2008; 58(7):323-7. PubMed ID: 18751497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the intragastric location of extended release tablets on food interactions.
    Weitschies W; Wedemeyer RS; Kosch O; Fach K; Nagel S; Söderlind E; Trahms L; Abrahamsson B; Mönnikes H
    J Control Release; 2005 Nov; 108(2-3):375-85. PubMed ID: 16213057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative bioavailability of Cardizem CD and Tiazac controlled-release diltiazem dosage forms after single and multiple dosing in healthy volunteers.
    Dimmitt DC; Bhargava VO; Arumugham T; Eller M; Weir SJ
    Am J Ther; 1998 May; 5(3):173-9. PubMed ID: 10099056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative bioavailability cf two amlodipine formulation in healthy volunteers.
    Setiawati E; Sukmayadi ; Yunaidi DA; Handayani LR; Harinanto G; Santoso ID; Deniati SH
    Arzneimittelforschung; 2007; 57(7):467-71. PubMed ID: 17803060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study.
    Choi Y; Lee S; Cho SM; Kang WH; Nam KY; Jang IJ; Yu KS
    Drug Des Devel Ther; 2016; 10():3021-3028. PubMed ID: 27703330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.